Search Results - Velugonda, Nagaraj

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects

    AMPK-induced novel phosphorylation of RUNX1 inhibits STAT3 activation and overcome imatinib resistance in chronic myelogenous leukemia (CML) subjects by Gayatri, Meher Bolisetti, Kancha, Rama Krishna, Behera, Abhayananda, Patchva, Dorababu, Velugonda, Nagaraj, Gundeti, Sadasivudu, Reddy, Aramati Bindu Madhava

    Published in Cell death discovery
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia

    Metformin exerts antileukemic effects by modulating lactate metabolism and overcomes imatinib resistance in chronic myelogenous leukemia by Gayatri, Meher Bolisetti, Kancha, Rama Krishna, Patchva, Dorababu, Velugonda, Nagaraj, Gundeti, Sadashivudu, Reddy, Aramati B M

    Published in The FEBS journal
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    In vitro cytotoxicity analysis on patient-derived PBMCs to predict 6-mercaptopurine therapy response in children with acute lymphoblastic leukemia

    In vitro cytotoxicity analysis on patient-derived PBMCs to predict 6-mercaptopurine therapy response in children with acute lymphoblastic leukemia

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: